Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-015-1186-0
Published Online: 2015-03-26
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Broecker-Preuss, Martina
Müller, Stefan
Britten, Martin
Worm, Karl
Schmid, Kurt Werner
Mann, Klaus
Fuhrer, Dagmar
License valid from 2015-03-26